Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > ALL THE BEST
View:
Post by goldyhawk on Apr 27, 2023 10:05am

ALL THE BEST

have been selling lately to move in to something more risky 
Will have none by the next week or two   

Got tired of waiting 

GLTA
Comment by goldyhawk on Apr 27, 2023 10:35am
Note!!! nothing against MEDMIRA  notice I said I am moving to something MORE RISKY  Medmira will do whatever whenever with or without whomever as a shareholder 
Comment by Petey78 on Apr 27, 2023 1:11pm
Come on Goldy. Stuck around. You're going to miss my "HAHAHAHHAHAHAHA"'s. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities